Tranexamic acid use during total hip arthroplasty: A single center retrospective analysis

BACKGROUND: Tranexamic acid (TXA) is an antifibrinolytic agent that has shown promise in reducing blood loss during total hip arthroplasty (THA). Several studies have reported side effects of high-dose TXA administration, including myocardial infarction (MI), thromboembolic events, and seizures. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoicea, Nicoleta, Moran, Kenneth, Mahmoud, Abdel-Rasoul, Glassman, Andrew, Ellis, Thomas, Ryan, John, Granger, Jeffrey, Joseph, Nicholas, Salon, Nathan, Ackermann, Wiebke, Rogers, Barbara, Niermeyer, Weston, Bergese, Sergio D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392984/
https://www.ncbi.nlm.nih.gov/pubmed/29794747
http://dx.doi.org/10.1097/MD.0000000000010720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392984/
https://www.ncbi.nlm.nih.gov/pubmed/29794747
http://dx.doi.org/10.1097/MD.0000000000010720

Ejemplares similares